2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö : 2024-02-03 |
|
2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö : 2024-02-03 ±³À°ÁÖÁ¦ : 2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѳ²¼º°úÇÐȸ ´ã´çÀÚ : ÇãÀçÀº À̸ÞÀÏ : gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À° Âü¼®¿¹»óÀÎ : 100¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 20,000¿ø ºñ°í "Àü¹®ÀÇ: 20000¿ø (»çÀü, ÇöÀå µ¿ÀÏ) Àü°øÀÇ, °£È£»ç, ¿¬±¸¿ø : 10000 (»çÀü, ÇöÀå µ¿ÀÏ)"
±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 10:50~11:05 Hormonal imbalance and Depression ÀÌÈ¿µ(¼øõÇâÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 11:05~11:20 Hormonal imbalance and Obesity ¾È¼øÅÂ(°í·ÁÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 11:20~11:35 Hormonal imbalance and Osteoporosis ±èµ¿¼ö(°æÈñÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 11:35~11:50 Hormone therapy for Transgender patients ÀÌ»ó¹è(ÇѸ²ÀÇ´ë ³»ºÐºñ³»°ú) Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 11:50~12:00 ÆгÎÅäÀÇ ¹Î±Ç½Ä, ÇãÁ¤½Ä, ¹ÚÇöÁØ, ÀÌ¿ø±â(ÀÎÁ¦ÀÇ´ë, Á¦ÁÖÀÇ´ë, ºÎ»êÀÇ´ë, ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 12:50~13:05 Testosterone level and Premature ejacultation °¨¼ºÃ¶(°æ»óÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 13:05~13:20 Prevention of Late-onset male hypogonadism ½ÅÀ¯¼·(ÀüºÏÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 13:20~13:35 Hormonal imbalance and Infertility ±è´ë±Ù(Â÷ÀÇ°úÇдë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 13:35~13:50 Hormonal imbalance and sexual dysfunction ÀÌÁØÈ£(À»ÁöÀÇ´ë) Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 13:50~14:00 ÆгÎÅäÀÇ ½ÅÈ«¼®, ±è¼±¿Á, ¼Û½ÂÈÆ, Á¶¹Îö, õ¿øÈñ(´ë±¸°¡Å縯ÀÇ´ë, Àü³²ÀÇ´ë, Â÷ÀÇ°úÇдë, ¼¿ïÀÇ´ë, ´öõ¿äÆíÇѺñ´¢±â°úÀÇ¿ø) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 14:20~14:35 Testosterone replacement therapy in men with BPH or CP/CPPS ¹Úµ¿Áø(µ¿±¹ÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 14:35~14:50 Testosterone replacement therapy for Testicular cancer ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 14:50~15:05 Role of androgen receptor in Urothelial carcinoma ÇÏÀ±¼®(°æºÏÀÇ´ë) ±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 15:05~15:20 Current hormone treatment options for mHSPC and mCRPC ÃÖÁøºÀ(°¡Å縯ÀÇ´ë) Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°´ç 15:20~15:30 ÆгÎÅäÀÇ ·ùÁö°£, ÀÌÇйÎ, ¹Ú¹Î±¸, Á¤Çöö(ÀÎÇÏÀÇ´ë, ¼¿ïÀÇ´ë, °í·ÁÀÇ´ë, ÇѸ²ÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|